| APGE | Apogee Therapeutics Inc | 4.36% |
| CGON | CG Oncology Inc | 3.33% |
| XENE | Xenon Pharmaceuticals Inc | 3.09% |
| ORKA | Oruka Therapeutics Inc | 3.05% |
| DNTH | Dianthus Therapeutics Inc | 2.83% |
| TVTX | Travere Therapeutics Inc Ordinary Shares | 2.80% |
| DFTX | Definium Therapeutics Inc Ordinary Shares | 2.73% |
| MANE | Veradermics Inc | 2.72% |
| EWTX | Edgewise Therapeutics Inc | 2.32% |
| ACAD | ACADIA Pharmaceuticals Inc | 2.30% |
The ALPS Medical Breakthroughs ETF (SBIO) seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the S-Network Medical Breakthroughs Index (PMBI).
ALPS Medical Breakthroughs ETF · Issued by SS&C
No recent news for SBIO. The ingest cron pulls every 15 minutes during market hours.